Results 131 to 140 of about 136,671,996 (217)

[Subtypes H1N1 and H3N2 of influenza virus isolated from the same patient].

Uirusu, 1987
M, Sakoh, T, Nakayama, K, Aihara, T, Oka, S, Nonaka, K, Nerome, A, Oya, K, Ueda   +7 more
openaire   +1 more source

Clinical outcomes during the 2025-2026 and 2024-2025 influenza seasons in a US EHR network: an ecological comparison during A(H3N2) subclade K predominance. [PDF]

IJID Reg
Kitano T, Yoshida S.
europepmc   +1 more source

Epitope-guided optimization improves the protective efficacy of NA-based mRNA vaccines against seasonal influenza A(H3N2) virus. [PDF]

J Microbiol
Kim H, Lee S, Cho S, Shin W, Lee S, Demirev AV, Lee T, Kim YJ, Kim D, Song SA, Jun KR, Kim JI.   +11 more
europepmc   +1 more source

Faster waning of immunity to influenza vaccine strains reintroduced into subsequent seasons: A human cohort study. [PDF]

Vaccine
Cheng C, Chen X, Ge Y, Sung MH, Zuo J, Carlock MA, Hanley HB, Ross TM, Handel A, Shen Y.   +9 more
europepmc   +1 more source

Detection and characterization of antiviral-resistant viruses during the influenza season of 2024-25. [PDF]

Microbiol Spectr
Patel MC, Nguyen HT, Pascua PNQ, Lopez-Esteva M, Champion C, Mishin VP, Di H, Lacek K, Kirby MK, Bateman A, Sullivan M, Trow S, Laplante J, St George K, Rambo-Martin B, Merced-Morales A, Budd A, Kondor RJ, Davis CT, Gubareva LV.   +19 more
europepmc   +1 more source

A neuraminidase-targeting nanobody as a therapeutic candidate against influenza A and B viruses. [PDF]

J Virol
Liu D, Zhang Y, Zhang M, Guo R, Peng W, Cao R, Yang X, Chen J, Huang S, Li J, Sheng C, Qin L.   +11 more
europepmc   +1 more source

Population Immunity to Influenza Neuraminidase: From Immune Imprinting to Pandemic Preparedness. [PDF]

Vaccines (Basel)
Liew KY, Sari TK, Tan YJ.
europepmc   +1 more source

Epidemiology, temporal trends and co-infection of 13 respiratory pathogens in 32,125 children: a 3-year retrospective study. [PDF]

Front Pediatr
Zhang Y, Wang S, Huang X.
europepmc   +1 more source

The roles of pre-season immunity, age, viral shedding, and community exposures in shaping influenza household transmission dynamics. [PDF]

Nat Commun
Sauter MK, Kleynhans J, Moyes J, McMorrow ML, Treurnicht FK, Hellferscee O, von Gottberg A, Wolter N, Buys A, Maake L, Martinson NA, Kahn K, Lebina L, Motlhaoleng K, Wafawanaka F, Gómez-Olivé FX, Tempia S, Grenfell B, Viboud C, Sun K, Cohen C.   +20 more
europepmc   +1 more source

Multivalent antiviral conjugates enhance activity against Influenza via cross-linking viruses. [PDF]

Nat Commun
Feng X, Yuan L, Zhao L, Liu L, Xie F, Zhou M, Cheng G, Guan Y, Xia N, Cheng T, Zhong W, Xiao D, Zhou X, Li S.   +13 more
europepmc   +1 more source